Prostatic Neoplasms, Castration-Resistant Active Not Recruiting Phase 1 Trials for Enzalutamide (DB08899)

IndicationStatusPhase
DBCOND0001230 (Prostatic Neoplasms, Castration-Resistant)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02204072BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)Treatment